Price History
Feb 9, 2026 — May 24, 2026Investment Snapshot
- Trading 87% below Graham Number ($0.98) — significant margin of safety
- Piotroski F-Score 2/9 — signs of financial weakness
- Loss-making — negative ROE of -170.0%
- Revenue declining 81% annually
SRX Health Solutions, Inc. Common Stock (SRXH) is a Consumer Defensive company operating in Beverages, listed on the AMEX , with a market capitalisation of $75 million . Key value metrics: P/E ratio 0.1, P/B ratio 4.10, Piotroski F-Score 2 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
SRX Health Solutions, Inc. Common Stock — Fundamental Analysis Summary
SRX Health Solutions, Inc. Common Stock (SRXH) is trading 87% below its Graham Number of $0.98 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 0.1x.
On financial health, SRXH shows a weak Piotroski F-Score of 2/9, a signal of deteriorating financial health, and negative return on equity of -170.0% (sector average: 4.9%), and minimal leverage with a debt-to-equity ratio of 0.22.
StockPik's composite Value Score for SRXH is 47/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SRXH reports a moderate gross margin of 32.7% (sector average: 24.8%) and a negative operating margin of -97.0%.
SRXH shows revenue declining at 81% year-over-year, with earnings declining at 26,689%.